India · English
Jubilant Pharmova approves ₹800 crore NCD issue through private placement
The pharmaceutical company’s board has cleared the debt issue, with the interest rate to be determined through the bidding process.
Read the full report at The Hindu BusinessLine →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.